{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:44:47Z","timestamp":1787021087482,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Small vessel coronary artery disease presents challenges in percutaneous coronary intervention due to higher restenosis rates with traditional treatments. Drug-coated balloons (DCBs) offer a potential alternative, but their efficacy compared to drug-eluting stents (DES) remains debated. This meta-analysis aims to provide updated insights into the comparative outcomes of DCBs versus DES in small coronary artery disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main text<\/jats:title>\n                    <jats:p>\n                      Following PRISMA guidelines, a systematic review identified seven randomized controlled trials (RCTs) comparing DCBs with DES for small vessel CAD. Data were extracted and pooled for analysis, assessing outcomes including target lesion revascularization (TLR), target vessel revascularization (TVR), mortality, myocardial infarction (MI), stent\/vessel thrombosis, and major adverse cardiovascular events (MACE). Statistical analysis was performed using RevMan version 5.4, employing random-effects models and forest plots with odds ratios (OR) and 95% confidence intervals (CI). Among 1,808 patients across seven RCTs, no significant difference was found in TVR between DCB and DES over 3\u00a0years (OR\u2009=\u20090.95, 95% CI [0.58, 1.54],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.82). While initial analyses favoured higher TLR incidence in DES, the trend shifted towards DCB over time, with a non-significant association favouring DCB at 3\u00a0years (OR\u2009=\u20090.51, 95% CI [0.26, 1.00],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05). DCB use was associated with significantly higher rates of MACE and MI at the 3-year mark (MACE: OR\u2009=\u20090.55, 95% CI [0.38, 0.79],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001; MI: OR\u2009=\u20090.35, 95% CI [0.17, 0.7],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), while mortality rates converged between the two interventions over time. Vessel thrombosis rates were similar between DCB and DES.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While DCBs may offer comparable efficacy to DES in terms of TVR and TLR over shorter durations, there is a concerning trend towards higher rates of MACE and MI associated with DCB use at the 3-year mark. Further research with larger sample sizes, longer follow-up durations, and consistent inclusion criteria is needed to elucidate the optimal treatment strategy for small vessel CAD. Until then, DES may be considered a safer option for managing small vessel CAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-025-00621-7","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:14:34Z","timestamp":1740543274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative efficacy and safety of drug-coated balloons versus drug-eluting stents in small vessel coronary artery disease: an updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"77","author":[{"given":"Monisha","family":"Augustine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Arain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-3543","authenticated-orcid":false,"given":"Muhammad Saqlain","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fredericks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaliya","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Afnan","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glawish","family":"Sualeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubab","family":"khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqsa","family":"Saif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Arain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip Baldevsingh","family":"Rajpurohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalkareem Nael Jameel","family":"Maslamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Shojai Rahnama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"12","key":"621_CR1","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.106.621359","volume":"116","author":"A Colombo","year":"2007","unstructured":"Colombo A, Chieffo A (2007) Drug-eluting stent update 2007. Circulation 116(12):1424\u20131432. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.621359","journal-title":"Circulation"},{"issue":"5","key":"621_CR2","doi-asserted-by":"publisher","first-page":"100403","DOI":"10.1016\/j.jscai.2022.100403","volume":"1","author":"S-S Jorge","year":"2022","unstructured":"Jorge S-S, Mauro C, Gauravpal SG et al (2022) Small vessel coronary artery disease: rationale for standardized definition and critical appraisal of the literature. J Soc Cardiovasc Angiogr Interv 1(5):100403. https:\/\/doi.org\/10.1016\/j.jscai.2022.100403","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"24","key":"621_CR3","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","volume":"60","author":"A Latib","year":"2012","unstructured":"Latib A, Colombo A, Castriota F et al (2012) A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon elution and late loss optimization) study. J Am Coll Cardiol 60(24):2473\u20132480. https:\/\/doi.org\/10.1016\/j.jacc.2012.09.020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"621_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1161\/circinterventions.113.001146","volume":"7","author":"TC Poerner","year":"2014","unstructured":"Poerner TC, Otto S, Gassdorf J et al (2014) Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6\u00a0months follow-up. Circ Cardiovasc Interv 7(6):760\u2013767. https:\/\/doi.org\/10.1161\/circinterventions.113.001146","journal-title":"Circ Cardiovasc Interv"},{"issue":"04","key":"621_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0038-1624066","volume":"2","author":"L Nemani","year":"2017","unstructured":"Nemani L (2017) Small vessel angioplasty. Indian J Cardiovasc Disease Women WINCARS 2(04):111\u2013118","journal-title":"Indian J Cardiovasc Disease Women WINCARS"},{"issue":"10261","key":"621_CR6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/s0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow MA et al (2020) Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet 396(10261):1504\u20131510. https:\/\/doi.org\/10.1016\/s0140-6736(20)32173-5","journal-title":"Lancet"},{"issue":"7","key":"621_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jcin.2019.10.062","volume":"13","author":"A Silverio","year":"2020","unstructured":"Silverio A, Buccheri S, Venetsanos D et al (2020) Percutaneous treatment and outcomes of small coronary vessels: a SCAAR report. JACC Cardiovasc Interv 13(7):793\u2013804. https:\/\/doi.org\/10.1016\/j.jcin.2019.10.062","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"621_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ccd.29111","volume":"98","author":"J Sanz S\u00e1nchez","year":"2021","unstructured":"Sanz S\u00e1nchez J, Chiarito M, Cortese B et al (2021) Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: a meta-analysis of randomized trials. Catheter Cardiovasc Interv 98(1):66\u201375. https:\/\/doi.org\/10.1002\/ccd.29111","journal-title":"Catheter Cardiovasc Interv"},{"key":"621_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"16","key":"621_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","volume":"96","author":"B Cortese","year":"2010","unstructured":"Cortese B, Micheli A, Picchi A et al (2010) Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. PICCOLETO Study Heart 96(16):1291\u20131296. https:\/\/doi.org\/10.1136\/hrt.2010.195057","journal-title":"PICCOLETO Study Heart"},{"key":"621_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2015.01.080","volume":"184","author":"T Naganuma","year":"2015","unstructured":"Naganuma T, Latib A, Sgueglia GA et al (2015) A 2\u00a0years follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol 184:17\u201321. https:\/\/doi.org\/10.1016\/j.ijcard.2015.01.080","journal-title":"Int J Cardiol"},{"issue":"8","key":"621_CR12","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcin.2015.04.008","volume":"8","author":"A Latib","year":"2015","unstructured":"Latib A, Ruparelia N, Menozzi A et al (2015) 3-year follow-up of the balloon elution and late loss optimization study (BELLO). JACC Cardiovasc Interv 8(8):1132\u20131134. https:\/\/doi.org\/10.1016\/j.jcin.2015.04.008","journal-title":"JACC Cardiovasc Interv"},{"issue":"10150","key":"621_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(18)31719-7","volume":"392","author":"RV Jeger","year":"2018","unstructured":"Jeger RV, Farah A, Ohlow MA et al (2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 392(10150):849\u2013856. https:\/\/doi.org\/10.1016\/s0140-6736(18)31719-7","journal-title":"Lancet"},{"issue":"23","key":"621_CR14","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","volume":"11","author":"Y Tang","year":"2018","unstructured":"Tang Y, Qiao S, Su X et al (2018) Drug-coated balloon versus drug-eluting stent for small-vessel disease: the restore SVD china randomized trial. JACC Cardiovasc Interv 11(23):2381\u20132392. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.009","journal-title":"JACC Cardiovasc Interv"},{"issue":"Suppl 1","key":"621_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ccd.28705","volume":"95","author":"J Tian","year":"2020","unstructured":"Tian J, Tang YD, Qiao S et al (2020) Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial. Catheter Cardiovasc Interv 95(Suppl 1):587\u2013597. https:\/\/doi.org\/10.1002\/ccd.28705","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"621_CR16","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","volume":"13","author":"B Cortese","year":"2020","unstructured":"Cortese B, Di Palma G, Guimaraes MG et al (2020) Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial. JACC Cardiovasc Interv 13(24):2840\u20132849. https:\/\/doi.org\/10.1016\/j.jcin.2020.08.035","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"621_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jcin.2023.02.011","volume":"16","author":"B Cortese","year":"2023","unstructured":"Cortese B, Testa G, Rivero F, Erriquez A, Alfonso F (2023) long-term outcome of drug-coated balloon vs drug-eluting stent for small coronary vessels: PICCOLETO-II 3-year follow-up. JACC Cardiovasc Interv 16(9):1054\u20131061. https:\/\/doi.org\/10.1016\/j.jcin.2023.02.011","journal-title":"JACC Cardiovasc Interv"},{"key":"621_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amjcard.2023.05.057","volume":"211","author":"S Liu","year":"2024","unstructured":"Liu S, Zhou Y, Shen Z et al (2024) comparison of drug-coated balloon and drug-eluting stent for the treatment of small vessel disease (from the dissolve SVD randomized trial). Am J Cardiol 211:29\u201339. https:\/\/doi.org\/10.1016\/j.amjcard.2023.05.057","journal-title":"Am J Cardiol"},{"issue":"6","key":"621_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4244\/eij-d-17-00494","volume":"13","author":"F Alfonso","year":"2017","unstructured":"Alfonso F, Scheller B (2017) State of the art: balloon catheter technologies\u2014 drug-coated balloon. EuroIntervention 13(6):680\u2013695. https:\/\/doi.org\/10.4244\/eij-d-17-00494","journal-title":"EuroIntervention"},{"key":"621_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.carrev.2021.03.008","volume":"35","author":"M Megaly","year":"2022","unstructured":"Megaly M, Buda K, Saad M et al (2022) Outcomes with drug-coated balloons vs. drug-eluting stents in small-vessel coronary artery disease. Cardiovasc Revasc Med 35:76\u201382. https:\/\/doi.org\/10.1016\/j.carrev.2021.03.008","journal-title":"Cardiovasc Revasc Med"},{"issue":"4","key":"621_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.14715\/cmb\/2024.70.4.31","volume":"70","author":"X Cai","year":"2024","unstructured":"Cai X, Hong X, Wang Y, Li Y, Xu G (2024) Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography. Cell Mol Biol 70(4):196\u2013201","journal-title":"Cell Mol Biol"},{"issue":"1","key":"621_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12872-023-03633-w","volume":"23","author":"A Abdelaziz","year":"2023","unstructured":"Abdelaziz A, Hafez A, Atta K et al (2023) Drug-coated balloons versus drug-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention: an updated meta-analysis with trial sequential analysis. BMC Cardiovasc Disord 23(1):605. https:\/\/doi.org\/10.1186\/s12872-023-03633-w","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"621_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ccd.23397","volume":"80","author":"LA Cannon","year":"2012","unstructured":"Cannon LA, Simon DI, Kereiakes D et al (2012) The XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT Small vessel trial. Catheter Cardiovasc Interv 80(4):546\u2013553. https:\/\/doi.org\/10.1002\/ccd.23397","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"621_CR24","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"4","author":"BE Claessen","year":"2011","unstructured":"Claessen BE, Smits PC, Kereiakes DJ et al (2011) Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (clinical evaluation of the XIENCE V everolimus eluting coronary stent system) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. JACC Cardiovasc Interv 4(11):1209\u20131215. https:\/\/doi.org\/10.1016\/j.jcin.2011.07.016","journal-title":"JACC Cardiovasc Interv"},{"key":"621_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ahj.2016.02.020","volume":"176","author":"LC van der Heijden","year":"2016","unstructured":"van der Heijden LC, Kok MM, Danse PW et al (2016) Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial. Am Heart J 176:28\u201335. https:\/\/doi.org\/10.1016\/j.ahj.2016.02.020","journal-title":"Am Heart J"},{"issue":"5","key":"621_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5935\/abc.20160043","volume":"106","author":"D Kawecki","year":"2016","unstructured":"Kawecki D, Morawiec B, Dola J et al (2016) First-versus second-generation drug-eluting stents in acute coronary syndromes (Katowice-Zabrze Registry). Arq Bras Cardiol 106(5):373\u2013381. https:\/\/doi.org\/10.5935\/abc.20160043","journal-title":"Arq Bras Cardiol"},{"issue":"12","key":"621_CR27","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.amjcard.2018.02.033","volume":"121","author":"KD Buchanan","year":"2018","unstructured":"Buchanan KD, Torguson R, Rogers T et al (2018) In-stent restenosis of drug-eluting stents compared with a matched group of patients with de novo coronary artery stenosis. Am J Cardiol 121(12):1512\u20131518. https:\/\/doi.org\/10.1016\/j.amjcard.2018.02.033","journal-title":"Am J Cardiol"},{"issue":"25","key":"621_CR28","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1161\/circulationaha.104.513952","volume":"111","author":"L Mauri","year":"2005","unstructured":"Mauri L, Orav EJ, Kuntz RE (2005) Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111(25):3435\u20133442. https:\/\/doi.org\/10.1161\/circulationaha.104.513952","journal-title":"Circulation"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-025-00621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-025-00621-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-025-00621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:14:36Z","timestamp":1740543276000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-025-00621-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["621"],"URL":"https:\/\/doi.org\/10.1186\/s43044-025-00621-7","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}